Acute Kidney Injury

  • William S. Varade
  • Elif Erkan


Acute renal failure, now termed acute kidney injury (AKI), is a common occurrence in the pediatric intensive care unit. It impacts the management decisions and outcomes of critically ill patients. This chapter will review the factors involved in measuring renal function in children and recognizing abnormal renal function. The major clinical subtypes of AKI and how to distinguish between them will be addressed as well as some of the more common causes within each subtype. Management of AKI will be reviewed, including the indications for renal replacement therapy. The impact of impairment of renal function on the overall management and outcome of the critically ill pediatric patient will be discussed.


Peritoneal Dialysis Renal Replacement Therapy Acute Kidney Injury Fractional Excretion Renal Injury 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Readings

  1. Andreoli SP. Acute kidney injury in children. Pediatr Nephrol. 2009;24:253–63.PubMedCrossRefGoogle Scholar
  2. Askenazi DJ, Ambalavanan N, Goldstein SL. Acute kidney injury in critically ill newborns: what do we know? what do we need to learn? Pediatr Nephrol. 2009;24:265–74.PubMedCrossRefGoogle Scholar
  3. Barletta GM, Bunchman TE. Acute renal failure in children and infants. Curr Opin Crit Care. 2004;10:499–504.PubMedCrossRefGoogle Scholar
  4. Baskurt M, Okcun B, Abaci O, et al. N-acetylcysteine versus N-acetylcysteine  +  theophylline for the prevention of contrast nephropathy. Eur J Clin Invest. 2009;39:793–9.PubMedCrossRefGoogle Scholar
  5. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356:2139–43.PubMedCrossRefGoogle Scholar
  6. Bhat MA, Shah ZA, Makhdoomi MS, Mufti MH. Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial. J Pediatr. 2006;149:180–4.PubMedCrossRefGoogle Scholar
  7. Brady HR, Clarkson MR, Lieberthal W. Acute renal failure. In: Brenner B, editor. Brenner and Rector’s The kidney. 7th ed. St. Louis: Saunders; 2004. p. 1215–92.Google Scholar
  8. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol. 1994;267:F1059–62.PubMedGoogle Scholar
  9. Bunchman TE, McBryde KD, Mottes TE, et al. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol. 2001;16:1067–71.PubMedCrossRefGoogle Scholar
  10. Cantarovich MD, Rangoonwala B, Lorenz H, et al. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis. 2004;44:402–9.PubMedGoogle Scholar
  11. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002;62:2223–9.PubMedCrossRefGoogle Scholar
  12. De Vries AS, Bougeois M. Pharmacologic treatment of acute renal failure in sepsis. Curr Opin Crit Care. 2003;9:474–80.CrossRefGoogle Scholar
  13. Devarajan P. The future of pediatric acute kidney injury management–biomarkers. Semin Nephrol. 2008;28:493–8.PubMedCrossRefGoogle Scholar
  14. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221–6.PubMedCrossRefGoogle Scholar
  15. Dishart MK, Kellum JA. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure. Drugs. 2000;59:79–91.PubMedCrossRefGoogle Scholar
  16. Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. The comparative benefits of the fractional excretion of urea and sodium in various azotemic oliguric states. Nephron Clin Pract. 2010;114:145–50.CrossRefGoogle Scholar
  17. Drukker A, Guignard JP. Renal aspects of the term and preterm infant: a selective update. Curr Opin Pediatr. 2002;14:174–82.CrossRefGoogle Scholar
  18. Druml W. Acute renal failure is not a “cute” renal failure! Intensive Care Med. 2004;30:1886–90.PubMedCrossRefGoogle Scholar
  19. Durmaz I, Yagdi T, Calkavur T, et al. Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg. 2003;75:859–64.PubMedCrossRefGoogle Scholar
  20. Flynn JT. Choice of dialysis modality for management of pediatric acute renal failure. Pediatr Nephrol. 2002;17:61–9.PubMedCrossRefGoogle Scholar
  21. Foland JA, Fortenberry JD, Warshaw BL, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med. 2004;32:1771–6.PubMedCrossRefGoogle Scholar
  22. Galley HF. Renal-dose dopamine: will the message now get through? Lancet. 2000;356:2112–3.PubMedCrossRefGoogle Scholar
  23. Goldstein SL, Currier H, Graf CD, et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics. 2001;107: 1309–12.PubMedCrossRefGoogle Scholar
  24. Han WK, Bonventre JV. Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care. 2004;10:476–82.PubMedCrossRefGoogle Scholar
  25. Hsu CW, Symons JM. Acute kidney injury: can we improve prognosis? Pediatr Nephrol. 2010;25:2401–12.PubMedCrossRefGoogle Scholar
  26. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF: epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis. 2005;45:96–101.PubMedCrossRefGoogle Scholar
  27. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148:284–94.PubMedGoogle Scholar
  28. Knight EL, Verhave JC, Spiegleman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416–21.PubMedCrossRefGoogle Scholar
  29. Kuiper JW, Groenveld ABJ, Slutsky AS, et al. Mechanical ventilation and acute renal failure. Crit Care Med. 2005;33:1408–15.PubMedCrossRefGoogle Scholar
  30. Lameire N, Vanholder R. Pathophysiologic features and prevention of human and experimental acute tubular necrosis. J Am Soc Nephrol. 2001;12:S20–32.PubMedGoogle Scholar
  31. Lameire N, Vanholder R, van Biesen W. Loop diuretics for patients with acute renal failure: helpful or harmful? JAMA. 2002;288:2599–601.PubMedCrossRefGoogle Scholar
  32. Lameire N, De Vriese AS, Vanholder R. Prevention and nondialytic treatment of acute renal failure. Curr Opin Crit Care. 2003; 9:481–90.PubMedCrossRefGoogle Scholar
  33. Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med. 2004;32:21–30.PubMedCrossRefGoogle Scholar
  34. McLaughlin GE, Abitbol CL. Reversal of oliguric tacrolimus nephrotoxicity in children. Nephrol Dial Transplant. 2005;20:1471–5.PubMedCrossRefGoogle Scholar
  35. Mehta RL, Pascual MT, Soroko S, et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547–53.PubMedCrossRefGoogle Scholar
  36. Merenzi G, Bartorelli AL. Recent advances in the prevention of radiocontrast-induced nephropathy. Curr Opin Crit Care. 2004; 10:505–9.Google Scholar
  37. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291:2328–34.PubMedCrossRefGoogle Scholar
  38. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–8.PubMedCrossRefGoogle Scholar
  39. Moghal NE, Brockelbank JT, Meadow SR. A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol. 1998;49:91–5.PubMedGoogle Scholar
  40. Neveu H, Kleinknecht D, Brivet F, et al. The French Study Group on Acute Renal Failure. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. Nephrol Dial Transplant. 1996;11:293–9.PubMedGoogle Scholar
  41. Nolan CR, Kelleher SP. Eosinophiluria. Clin Lab Med. 1988; 8:555–65.PubMedGoogle Scholar
  42. O’Leary MJ, Bihari DJ. Preventing renal failure in the critically ill. BMJ. 2001;322:1437–9.PubMedCrossRefGoogle Scholar
  43. Rivers E, Nguyen B, Havstad S, et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345:1368–77.PubMedCrossRefGoogle Scholar
  44. Robertson J, Shilkofski N. Drugs in renal failure. In: Robertson J, Shilkofski N, editors. The Harriet Lane Handbook: a manual for pediatric house officers. 17th ed. Philadelphia: Mosby; 2005. p. 1053–68.Google Scholar
  45. Safirstein RL. Acute renal failure: from renal physiology to the renal transcriptome. Kidney Int. 2004;66(suppl 91):S62–6.CrossRefGoogle Scholar
  46. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159–69.PubMedCrossRefGoogle Scholar
  47. Schrier RW, Wang W, Poole B, et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004;114:5–14.PubMedGoogle Scholar
  48. Schwartz GJ, Haycock GB, Chir B, et al. Plasma creatinine and urea concentration in children: normal values for age and sex. J Pediatr. 1976;88:828–30.PubMedCrossRefGoogle Scholar
  49. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987;34:571–90.PubMedGoogle Scholar
  50. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant. 1997;12:2592–6.PubMedCrossRefGoogle Scholar
  51. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide on acute changes in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:403–11.CrossRefGoogle Scholar
  52. Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure. Crit Care Med. 2004;32:1669–77.PubMedCrossRefGoogle Scholar
  53. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–67.PubMedCrossRefGoogle Scholar
  54. Varade WS. Hemolytic uremic syndrome: reducing the risk. Contemp Pediatr. 2000;17:54–64.Google Scholar
  55. Veltri MA, Neu AM, Fivush BA, et al. Drug dosing during intermittent hemodialysis and continuous renal replacement therapy. Pediatr Drugs. 2004;6:45–65.CrossRefGoogle Scholar
  56. Williams DM, Sreedhar SS, Mickell JJ, et al. Acute kidney failure: a pediatric experience over 20 years. Arch Pediatr Adolesc Med. 2002;156:893–900.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2012

Authors and Affiliations

  1. 1.Pediatric Nephrology, Department of PediatricsUniversity of Rochester School of Medicine and Dentistry, Golisano Children’s HospitalRochesterUSA
  2. 2.Pediatric Nephrology, Department of PediatricsUniversity of Pittsburgh School of Medicine, Children’s Hospital of Pittsburgh of UPMCPittsburghUSA

Personalised recommendations